David Wilks
COO
Micro-Distributing
Read More
Jeff Milner
Sr. Vice President
eRAMx
Read More
Pursuant to Executive Order (EO) 12564 addressing the need for a Drug-Free Federal Workplace and Executive Order 13941 improving Rural Health and Telehealth Access, this briefing will review the efficiencies in utilizing telehealth for virtual drug testing. The advancement of technology combined with well-established virtual health procedures provides for improved efficiency, time savings and cost savings in drug and alcohol testing for pre-employment, post-accident, post-incident, reasonable suspicion, for cause, and random drug testing programs.
Procedures for adoption of Oral Fluid Specimen Testing for Drugs has been established by the Department of Transportation (DOT). In the ruling by the Federal Aviation Administration, the Federal Railroad Administration, the Federal Motor Carrier Safety Administration, and the Federal Transit Administration on 05/02/2023.
Agency Panelist Participation
Agency participation is encouraged for this briefing. If you or one of your colleagues would like to be a contributor or panelist in this discussion, please contact support@govbrief.us or call 888-818-8726 to coordinate your participation. GovBrief provides free access to all government presenters and will distribute all accompanying documentation at no charge.
Recommended attending personnel:
Recommended attendees for this briefing includes:
Important: This briefing uses a Zoom-based communication connection via your network. This briefing will be accessible via phone if you are unable to connect online and recorded versions will be distributed with closed caption for the hearing impaired. Instructions for login will be provided upon registration.
Topical Overview
Federal Initiatives
Current Drug Testing Review & Challenges
Comparing Traditional vs. Modern Testing
Virtual Drug Testing Case Studies
Next Steps
Closing Remarks